These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 4235824)
41. [Metabolic bone diseases. The value of standardized morphometric investigation of undecalcified bone]. Melsen F; Mosekilde L; Beck-Nielson H Ugeskr Laeger; 1975 Apr; 137(17):931-3. PubMed ID: 1145806 [No Abstract] [Full Text] [Related]
42. 2 NEW METHODS FOR THE STUDY OF OSTEOPOROSIS AND OTHER METABOLIC BONE DISEASE. HURXTHAL LM; DOTTER WE; BAYLINK DJ; CLERKIN EP Lahey Clin Found Bull; 1964; 13():155-66. PubMed ID: 14163659 [No Abstract] [Full Text] [Related]
43. [Osteomalacia and severe backache as a complication of long-term intake of Novalucol]. Fredstorp L; Eyrich R Lakartidningen; 1984 Feb; 81(5):359-60. PubMed ID: 6230495 [No Abstract] [Full Text] [Related]
44. [Low back pain and instability of the pelvic ring]. Brun JG; Haga HJ Tidsskr Nor Laegeforen; 1989 Feb; 109(6):681-3. PubMed ID: 2522251 [TBL] [Abstract][Full Text] [Related]
45. [Diagnostic and therapeutic procedures in cases of backache caused by postmenopausal osteoporosis]. Płoucha K; Cekański A Ginekol Pol; 1977 Dec; 48(12):1053-7. PubMed ID: 146651 [No Abstract] [Full Text] [Related]
47. [Osteoporosis associated with endocrine dysfunctions or metabolic disorders]. Tomita A Nihon Rinsho; 1994 Sep; 52(9):2415-9. PubMed ID: 7967090 [TBL] [Abstract][Full Text] [Related]
48. Is periodontal disease a metabolic bone disorder? Lesser GV; Berens DL; Krook L N Y State Dent J; 1978 Jan; 44(1):17-8. PubMed ID: 339135 [No Abstract] [Full Text] [Related]
49. Osteoporosis and estrogen deprivation. Risk prediction and diagnosis: an overview. Chesnut CH Postgrad Med; 1989 Apr; Spec No():5-6; discussion 33-43. PubMed ID: 2726626 [No Abstract] [Full Text] [Related]
50. [Disorders of calcium metabolism in kidney failure]. Ritz E; Krempien B; Andrassy K Med Klin; 1972 Sep; 67(36):1129-32. PubMed ID: 4561354 [No Abstract] [Full Text] [Related]
51. [Osteoporosis and metabolic bone diseases; clinical relationship]. Klaushofer K; Roschger P; Nader A; Glantschnig H; Varga F Wien Med Wochenschr; 1999; 149(16-17):463-71. PubMed ID: 10627983 [TBL] [Abstract][Full Text] [Related]
52. [RESORPTION DISORDERS IN RELATION TO CALCIPENIC OSTEOPATHIES]. KUHLENCORDT F; LOZANO-TONKIN C Verh Dtsch Ges Inn Med; 1964; 70():902-8. PubMed ID: 14294326 [No Abstract] [Full Text] [Related]
53. [INITIAL RESULTS OF THE DYNAMIC EXPLORATION OF RAREFYING OSTEOPATHIES USING CA 47]. TABAU R Rev Rhum Mal Osteoartic; 1964 Jul; 31():356-8. PubMed ID: 14183690 [No Abstract] [Full Text] [Related]
54. Special procedures for assessing metabolic bone disease. Riggs BL; Jowsey J; Kelly PJ; Wahner HW Med Clin North Am; 1970 Jul; 54(4):1061-70. PubMed ID: 5425109 [No Abstract] [Full Text] [Related]
55. [CLINICAL SIGNIFICANCE OF BONE BIOPSY]. BARTELHEIMER H Verh Dtsch Ges Pathol; 1963; 47():129-41. PubMed ID: 14168334 [No Abstract] [Full Text] [Related]
56. A rare cause of severe dyspareunia: post-osteomalacic contracted pelvic outlet. Dane C; Dane B; Kural C Acta Obstet Gynecol Scand; 2005 Apr; 84(4):407-8. PubMed ID: 15762977 [No Abstract] [Full Text] [Related]
60. [Stanozolol in the treatment of diffuse decalcifying osteopathies]. Samuel J; Lumbroso A Sem Ther; 1964; 40(6):412-5. PubMed ID: 5878561 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]